← 產業報告目錄
Cell & Gene Therapy Raw Material Testing Market Size, Share & Trends Analysis Report By Service (Sterility Testing, Mycoplasma Detection Assays, Endotoxin Detection, Bioburden Testing, and Others), By Type, Region And Segment Forecasts, 2023-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-13頁數 180報告編號 INSIGHTACE-ec1a88321a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the Cell & Gene Therapy Raw Material Testing Market globally will surge at a 18.8% CAGR during 2023–2031.
The Cell & Gene Therapy Raw Material Testing sector involves dynamics.
Market momentum is propelled by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell & Gene Service Raw Material Testing Market Snapshot
Chapter 4. Global Cell & Gene Service Raw Material Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Estimates & Trend Analysis
5.1. By Service & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Service:
5.2.1. Sterility Testing
5.2.2. Mycoplasma Detection Assays
5.2.3. Endotoxin Detection
5.2.4. Bioburden Testing
5.2.5. Others
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2020 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type:
6.2.1. Cell Therapy
6.2.2. Gene Therapy
Chapter 7. Cell & Gene Service Raw Material Testing Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) estimates and forecasts By Service, 2020-2030
7.1.2. North America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) estimates and forecasts By Type, 2020-2030
7.1.3. North America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
7.2. Europe
7.2.1. Europe Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Service, 2020-2030
7.2.2. Europe Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Type, 2020-2030
7.2.3. Europe Cell & Gene Service Raw Material Testing Market revenue (US$ Million) by country, 2020-2030
7.3. Asia Pacific
7.3.1. Asia Pacific Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Service, 2020-2030
7.3.2. Asia Pacific Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Type, 2020-2030
7.3.3. Asia Pacific Cell & Gene Service Raw Material Testing Market revenue (US$ Million) by country, 2020-2030
7.4. Latin America
7.4.1. Latin America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Service, (US$ Million)
7.4.2. Latin America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Type, (US$ Million)
7.4.3. Latin America Cell & Gene Service Raw Material Testing Market revenue (US$ Million) by country, 2020-2030
7.5. Middle East & Africa
7.5.1. Middle East & Africa Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Service, (US$ Million)
7.5.2. Middle East & Africa Cell & Gene Service Raw Material Testing Market revenue (US$ Million) By Type, (US$ Million)
7.5.3. Middle East & Africa Cell & Gene Service Raw Material Testing Market revenue (US$ Million) by country, 2020-2030
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Thermo Fisher Scientific
8.2.2. Merck KGaA
8.2.3. Catalent Inc.
8.2.4. Charles River
8.2.5. Pace Analytical Life Sciences
8.2.6. Agilent Technologies
8.2.7. Intertek Group PLC
8.2.8. Element Material Technology
8.2.9. Eurofins Scientific
8.2.10. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們